GENTIAN DIAGNOSTIC
Research GENTIAN DIAGNOSTIC (GENT.OL) on Bullrun: market cap NOK 602.89M, dividend yield 1.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGENT.OL
- ExchangeXOSL
- CountryNorway
- SectorHealthcare
- IndustryMedical Devices
- CurrencyNOK
- Market capNOK 602.89M
- Dividend yield1.5%
- Financial periodQ2 2026
- RevenueNOK 49.77M
- Net incomeNOK 4.42M
- Free cash flow-NOK 3.30M
- Gross margin55.4%
Valuation Snapshot
latest market cap is NOK 602.89M; dividend yield is 1.5%.
Peer valuation comparison
Latest dividend yield is 1.53% versus a Healthcare sector median of 1.84% (16.8% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-10 | NOK 602.89M | n/a | 1.6% | 0.6 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.6 NOK, yield 1.5%.
About GENTIAN DIAGNOSTIC
Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. It offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Calprotectin Immunoassay, a turbidimetric assay used for the measurement of circulating calprotectin in plasma and serum for detection and assessment of inflammation;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is GENTIAN DIAGNOSTIC's market cap?
GENTIAN DIAGNOSTIC's market capitalization is NOK 602.89M.
Does GENTIAN DIAGNOSTIC pay a dividend?
GENTIAN DIAGNOSTIC has a dividend yield of 1.5%.
What does GENTIAN DIAGNOSTIC do?
Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe.